Tumor endothelial expression of P-glycoprotein upon microvesicular transfer of TrpC5 derived from adriamycin-resistant breast cancer cells

Biochemical and Biophysical Research Communications

Volumn 446, Issue 1, 2014, Pages 85-90

  Dong, Yeping ^a   Pan, Qiongxi ^a   Jiang, Li ^a   Chen, Zhen ^a   Zhang, Fangfang ^a   Liu, Yanjun ^a   Xing, Hui ^a   Shi, Mei ^a   Li, Jiao ^a   Li, Xiyuan ^a   Zhu, Yaodan ^a   Chen, Yun ^a   Bruce, Iain C ^a   Jin, Jian ^a   Ma, Xin ^a  

^a JIANGNAN UNIVERSITY   (China)

Author keywords

Drug resistant; Endothelial cells; Microvesicles; P gp expression

Indexed keywords

DOXORUBICIN; MULTIDRUG RESISTANCE PROTEIN 1; PACLITAXEL; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFATC3; TRANSIENT RECEPTOR POTENTIAL CHANNEL 5; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER RESISTANCE; CAPILLARY ENDOTHELIAL CELL; CELL COMMUNICATION; CELL DEATH; CELLULAR DISTRIBUTION; CHEMOSENSITIVITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MEMBRANE VESICLE; MICROVESICLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

DRUG-RESISTANT; ENDOTHELIAL CELLS; MICROVESICLES; P-GP EXPRESSION;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL COMMUNICATION; CELL-DERIVED MICROPARTICLES; CELLS, CULTURED; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION; HETEROGRAFTS; HUMANS; MCF-7 CELLS; MICE; MICE, NUDE; NFATC TRANSCRIPTION FACTORS; P-GLYCOPROTEIN; SIGNAL TRANSDUCTION; TRPC CATION CHANNELS; TUMOR MICROENVIRONMENT;

EID: 84897970924     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.02.076     Document Type: Article

References (35)

1. J. Folkman Tumor angiogenesis: therapeutic implications N. Engl. J. Med. 285 1971 1182 1186
2. G. Bergersand, and D. Hanahan Modes of resistance to anti-angiogenic therapy Nat. Rev. Cancer 8 2008 592 603
3. J.M. Ebos, C.R. Lee, J.G. Christense, A.J. Mutsaers, and R.S. Kerbel Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy Proc. Natl. Acad. Sci. U.S.A. 104 2007 17069 17074
4. J.M. Ebos, C.R. Lee, and R.S. Kerbel Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy Clin. Cancer Res. 15 2009 5020 5025
5. M. Pàez-Ribes, E. Allen, J. Hudock, T. Takeda, H. Okuyama, F. Viñals, M. Inoue, G. Bergers, D. Hanahan, and O. Casanovas Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis Cancer Cell 15 2009 220 231
6. A. Rapisard, and G. Melillo Role of the hypoxic tumor microenvironment in the resistance to anti-angiogenic therapies Drug Resist. Update 12 2009 74 80
7. Y.Q. Xiong, H.C. Sun, W. Zhang, X.D. Zhu, P.Y. Zhuang, J.B. Zhang, L. Wang, W.Z. Wu, L.X. Qin, and Z.Y. Tang Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells Clin. Cancer Res. 15 2009 4838 4846
8. K. Akiyama, N. Ohga, Y. Hida, T. Kawamoto, Y. Sadamoto, S. Ishikawa, N. Maishi, T. Akino, M. Kondoh, A. Matsuda, N. Inoue, M. Shindoh, and K. Hidia Tumor endothelial cells acquire drug resistance by MDR1 up-regulation via VEGF signaling in tumor microenvironment Am. J. Pathol. 180 2012 1283 1293
9. K. Hida, K. Akiyama, N. Ohga, N. Maishi, and Y. Hida Tumour endothelial cells acquire drug resistance in a tumour microenvironment J. Biochem. 153 2013 243 249
10. L. Huang, C. Perrault, J. Coelho-Martins, C. Hu, C. Dulong, M. Varna, J. Liu, C. Soria, L. Cazin, A. Janin, H. Li, R. Varin, and H. Lu Induction of acquired drug resistance in endothelial cells and its involvement in anticancer therapy J. Hematol. Oncol. 6 2013 1 12
11. C. Scheel, E.N. Eaton, S.H. Li, C.L. Chaffer, F. Reinhardt, K.J. Kah, G. Bell, W. Guo, J. Rubin, A.L. Richardson, and R.A. Weinerg Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast Cell 145 2011 926 940
12. M.A. Antonyak, B. Li, L.K. Boroughs, J.L. Johnson, J.E. Druso, K.L. Bryant, D.A. Holowka, and R.A. Cerione Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells Proc. Natl. Acad. Sci. U.S.A. 108 2011 4852 4857
13. J. Ratajczak, M. Wysoczynski, F. Hayek, A. Janowska-Wieczorek, and M. Ratajczak Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication Leukemia 20 2006 1487 1495
14. E. Pap, E. Pallinger, M. Pasztoi, and A. Falus Highlights of a new type of intercellular communication: microvesicle-based information transfer Inflamm. Res. 58 2009 1 8
15. A. Janowska-Wieczorek, M. Wysoczynski, J. Kijowski, L. Marquez-Curtis, B. Machalinski, J. Ratajczak, and M.Z. Ratajczak Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer Int. J. Cancer 113 2005 752 760
16. K. Koga, K. Matsumoto, T. Akiyoshi, M. Kubo, N. Yamanaka, A. Tasaki, H. Nakashima, M. Nakamura, S. Kuroki, M. Tanaka, and M. Katano Purification, characterization and biological significance of tumor-derived exosomes Anticancer Res. 25 2005 3703 3707
17. K. Al-Nedawi, B. Meehan, J. Micallef, V. Lhotak, L. May, A. Guha, and J. Rak Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells Nat. Cell Biol. 10 2008 619 624
18. C. D'Souza-Schoreyand, and J.W. Clancy Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers Genes Dev. 26 2012 1287 1299
19. D. Millimaggi, M. Mari, S. D'Ascenzo, E. Carosa, E.A. Jannini, S. Zucker, G. Carta, A. Pavan, and V. Dolo Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells Neoplasia 9 2007 349 357
20. K. Al-Nedawi, J. Szemraj, and C.S. Cierniewski Mast cell-derived exosomes activate endothelial cells to secrete plasminogen activator inhibitor type 1 Arterioscler. Thromb. Vasc. Biol. 25 2005 1744 1749
21. X. Ma, Y. Cai, D. He, C. Zou, P. Zhang, C.Y. Lo, Z. Xu, F.L. Chan, S. Yu, Y. Chen, R. Zhu, J. Lei, J. Jin, and X. Yao Transient receptor potential channel TRPC5 is essential for P-glycoprotein induction in drug-resistant cancer cells Proc. Natl. Acad. Sci. U.S.A. 109 2012 16282 16287
22. J.M. Nabholtz, J.R. Mackey, M. Smylie, A. Paterson, D.R. Noël, T. Al-Tweigeri, K. Tonkin, S. North, N. Azli, and A. Riva Phase II study of docetaxel, doxorubicin, and cyclophosphamide as first-line chemotherapy for metastatic breast cancer J. Clin. Oncol. 19 2001 314 321
23. N. Altan, Y. Chen, M. Schindler, and S.M. Simon Tamoxifen inhibits acidification in cells independent of the estrogen receptor Proc. Natl. Acad. Sci. U.S.A. 96 1999 4432 4437
24. M. Tanabe, I. Ieiri, N. Nagata, K. Inoue, S. Ito, Y. Kanamori, M. Takahashi, Y. Kurata, J. Kigawa, S. Higuchi, N. Terakawa, and K. Otsubo Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene J. Pharmacol. Exp. Ther. 297 2001 1137 1143
25. C. Montell, L. Birnbaumer, and V. Flockerzi The TRP channels, a remarkably functional family Cell 108 2002 595 598
26. K. Al-Nedawi, B. Meehan, R.S. Kerbel, A.C. Allison, and J. Rak Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR Proc. Natl. Acad. Sci. U.S.A. 106 2009 3794 3799
27. C. Komoto, T. Nakamura, M. Yamamori, N. Ohmoto, H. Kobayashi, A. Kuwahara, K. Nishiguchi, K. Takara, Y. Tanigawara, N. Okamura, K. Okamura, and T. Sakaeda Reversal effects of Ca2+ antagonists on multidrug resistance via down-regulation of MDR1 mRNA Kobe J. Med. Sci. 53 2008 355 363
28. A. Rao, C. Luo, and P.G. Hogan Transcription factors of the NFAT family: regulation and function Annu. Rev. Immunol. 15 1997 707 747
29. S.Z. Xu, F. Zeng, M. Lei, J. Li, B. Gao, C. Xiong, A. Sivaprasadarao, and D.J. Beech Generation of functional ion-channel tools by E3 targeting Nat. Biotechnol. 23 2005 1289 1293
30. B. St Croix, C. Rago, V. Velculescu, G. Traverso, K.E. Romans, E. Montgomery, A. Lai, G.J. Riggins, C. Lengauer, B. Vogelstein, and K.W. Kinzler Genes expressed in human tumor endothelium Science 289 2000 1197 1202
31. C. Riganti, I. Campia, M. Polimeni, G. Pescarmona, D. Ghigo, and A. Bosia Digoxin and ouabain induce P-glycoprotein by activating calmodulin kinase II and hypoxia-inducible factor-1α in human colon cancer cells Toxicol. Appl. Pharmacol. 240 2009 385 392
32. T. Ohba, H. Watanabe, M. Murakami, Y. Takahashi, K. Iino, S. Kuromitsu, Y. Mori, K. Ono, T. Iijima, and H. Ito Upregulation of TRPC1 in the development of cardiac hypertrophy J. Mol. Cell. Cardiol. 42 2007 498 507
33. M. Poteser, H. Schleifer, M. Lichtenegger, M. Schernthaner, T. Stockner, C.O. Kappe, N. Glasnov, C. Romanin, and K. Groschner PKC-dependent coupling of calcium permeation through transient receptor potential canonical 3 (TRPC3) to calcineurin signaling in HL-1 myocytes Proc. Natl. Acad. Sci. U.S.A. 108 2011 10556 10561
34. A. Piccin, W.G. Murphy, and O.P. Smith Circulating microparticles: pathophysiology and clinical implications Blood Rev. 21 2007 157 171
35. E.M. Bevers, P. Comfurius, D.W. Dekkers, M. Harmsma, and R. Zwaal Review: regulatory mechanisms of transmembrane phospholipid distributions and pathophysiological implications of transbilayer lipid scrambling Lupus 7 1998 S126 S131